Influx Healthtech Limited (NSE:INFLUX)
India · Delayed Price · Currency is INR 155.20
-2.85 (-1.80%)
At close: Aug 1, 2025
United States Steel Revenue
In the fiscal year ending March 31, 2025, Influx Healthtech had annual revenue of 1.05B INR with 4.89% growth. Influx Healthtech had revenue of 211.21M in the quarter ending June 30, 2024.
Revenue
1.05B
Revenue Growth
+4.89%
P/S Ratio
3.43
Revenue / Employee
6.43M
Employees
163
Market Cap
3.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.05B | 48.89M | 4.89% |
| Mar 31, 2024 | 999.65M | 239.09M | 31.44% |
| Mar 31, 2023 | 760.57M | 168.55M | 28.47% |
| Mar 31, 2022 | 592.02M | - | - |
| Mar 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 638.72B |